Clinical trials
Bacterial Infections clinical trials
Below are recruiting bacterial infections clinical trials, each written for real people, not researchers. We’re tracking 102 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06030245Recruiting
Tracking recovery from C. diff infection in hospital patients
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
ParisAges 18 years+ - NCT07708116RecruitingPhase 1
First human trial of CTX-187 for healthy people and those with chronic infection
This trial tests a new drug called CTX-187 in two groups: healthy volunteers (Parts A and B) and people with chronic lung infection from bronchiectasis (Part C). It helps find the right dose and checks safety.
GroningenAges 18–65 - NCT06515886Recruiting
Inflammation around dental implants: infection or allergy?
This study looks at why some dental implants get inflamed. It checks if the cause is a bacterial infection, an allergic reaction, or both. If you have a working dental implant that hasn't been treated for inflammation in the last three months, you might be able to join.
Montreal, QuebecAges 18 years+ - NCT06519032Recruiting
AI Tool for Faster Bacterial ID in Lung Tests
This trial is testing a new AI tool that quickly identifies bacteria from your AFB test sample. If your doctor ordered this test, you can help see if the AI works well.
Suita, OsakaAges Any age - NCT05645107RecruitingPhase 3
XEMBIFY plus usual care to prevent infections
This Phase 3 study tests whether XEMBIFY (an immune protein therapy) plus standard medical treatment can better prevent serious or repeated infections. It is for people with certain cancers of blood/immune systems who are already having trouble with infections.
Huntington Park, CaliforniaAges 18 years+ - NCT05350813Recruiting
Using procalcitonin to stop antibiotics earlier safely
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
AmiensAges 3 days–17 years - NCT05922124RecruitingPhase 4
Testing two antibiotics against resistant lung and bloodstream infections
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
HaifaAges 16 years+ - NCT07044726RecruitingPhase 4
Betadine vs sterile water for catheter cleaning
This trial compares using Betadine (an iodine-based antiseptic) versus sterile water to clean the area before a catheter is placed in the doctor's office. The goal is to see which method better prevents infections during the procedure.
Louisville, KentuckyAges 18 years+ - NCT06814899Recruiting
Fosfomycin for bacterial infections in hospitalized adults
This study looks at how well the antibiotic fosfomycin works for bacterial infections in patients who received it in the hospital. It may help doctors understand the best ways to use this medicine.
Lecco, LeccoAges 18 years+ - NCT07739004Recruiting
Fever in Children: Predictors of Serious Illness
This study looks at children with fever to find early signs that might predict serious illness, helping doctors make better triage decisions in the emergency room.
Kayseri, TalasAges birth–18 years - NCT04263792RecruitingPhase 1
Scan trial to track a new tracer in suspected bacterial infections
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04291768RecruitingPhase 4
Shorter 5-day antibiotics for certain gram-negative bloodstream infections
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
AalborgAges 18 years+ - NCT05302531RecruitingPhase 1
Testing high-absorption antibiotics for short-bowel syndrome
This early (Phase 1) study tests how well certain antibiotics get absorbed in the body when you have short-bowel syndrome. It may help doctors choose antibiotics that work better through the mouth for people with this digestion problem.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT05817825Recruiting
Remote program to support recovery after opioid use
This study tests a new intensive outpatient program delivered by video or phone to help people with opioid use disorder (and other substance use disorders) stay on track after leaving the hospital. It may help by offering structured support while you are at home.
Boston, MassachusettsAges 18 years+ - NCT05914779Recruiting
Early antibiotics after out-of-hospital cardiac arrest
This study looks at whether starting antibiotics soon after an out-of-hospital cardiac arrest helps patients who are unlikely to have an infection. Antibiotics may prevent or treat infection-related complications, but only if certain infection and health conditions are met.
Doha, Baladiyat ad DawhahAges 18 years+ - NCT06166381Recruiting
Antibiotics in ACL reconstruction: vein vs. vein plus soaked graft
This trial compares two methods for preventing infection during ACL reconstruction surgery. One group gets antibiotics through a vein, and the other group gets antibiotics through the vein plus a special antibiotic-soaked graft placed in the knee.
DuhokAges 20–45 - NCT06377592Recruiting
AI for Gram stain test accuracy
This trial is testing an AI tool that analyzes Gram stain test results. It is for patients who have had a Gram stain test ordered, which is a common lab test to identify bacteria. The study aims to see how well the AI works compared to standard methods.
Suita, OsakaAges Any age - NCT06427317Recruiting
Antibiotic effectiveness study in infection patients
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
LondonAges 18 years+ - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months - NCT07051525Recruiting
Early vs. late stopping of antibiotics for fever in blood cancer treatment
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Melbourne, VictoriaAges 18 years+ - NCT07062445Recruiting
Tracking treatment and outcomes for children with meningitis
This study follows children with meningitis to see how well treatments work and what happens in the long run. If your child has a fever and signs of meningitis (like a stiff neck, headache, or rash), they may be able to join.
São Paulo, São PauloAges Up to 17 years - NCT07104162RecruitingPhase 1
Testing an IV antibiotic in people with kidney problems
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
Miami, FloridaAges 18–80 - NCT07234786Recruiting
Vaginal gel for treating and preventing vaginal infections
This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.
Quatre BornesAges 18 years+ - NCT07285785RecruitingPhase 4
Rifaximin plus fluids versus fluids alone for kids with acute diarrhea
This trial compares a medicine called rifaximin (given with extra fluids) to just giving extra fluids to children ages 6 to 11 with diarrhea caused by bacteria. The goal is to see if adding rifaximin helps children get better faster.
Hialeah, FloridaAges 6–12
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bacterial infections?
- Yes. Clin2 currently lists 102 recruiting bacterial infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bacterial infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bacterial infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.